FdaApplication

NDA 217645

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTRIS PHARMA INC
application_typeNDA
approval_date2024-05-24

Products (1)

ProductActive ingredientStrengthDosage form
ONYDA XRCLONIDINE HYDROCHLORIDE0.1MG/MLSUSPENSION, EXTENDED RELEASE;ORAL

1 product